Newsletter | July 21, 2021

07.21.21 -- Developing A Vaccine For Type 1 Diabetes

From The Editor
Featured Editorial
Industry Insights
Biosimilars: Evolving Challenges And Considerations

Evolution of the biosimilar regulatory pathway will require manufacturers to ask critical questions about the implementation of legacy and novel technologies and procedures in downstream processing.

Robust Chinese Hamster Ovary (CHO) Cell Expression Platform For High-Quality Biomanufacturing

Rapid development of high-quality cell lines is vital to biomanufacturing projects. How developers approach the fundamental steps can define their core biologics capabilities and keep projects on track.

Bridging The Skills Gap In Biopharma

Employees must have the skills to effectively execute on process development and manufacturing operations. How do you ensure they are updated on complex bioprocessing techniques and technologies?

Accelerate Time To A Robust And Reliable Commercial-Scale Process

This five-step platform approach to process characterization ensures the entire process is right the first time and results in a highly consistent product to facilitate efficient biologics license application (BLA) filing.

How Can CDMOs Identify Their Customers' Decision-Making Process?

ISR was engaged by the global marketing director at a Top 20 CDMO with the above question. The client had years of experience in marketing their brand to prospective customers but had recently begun to question the efficiency of their marketing spend. The client wanted to demonstrate to their company stakeholders that their marketing efforts were not only hitting the right targets, but that the language used in those efforts reflected their customers’ needs. Knowing this information would allow the client’s marketing department to move away from broad, product-based messaging focused on how good their services are, to messaging focused on how their services address their customers’ concerns.

Eliminate Drug Discovery Errors Before They Happen: Why Picking The Correct Binding Technology Is Critical To Success

Starting with the right tool is crucial in saving you time and money in the drug development process. This binding technologies toolbox covers temperature-related intensity change (TRIC), surface plasmon resonance (SPR), differential scanning fluorimetry (DSF), and isothermal titration calorimetry (ITC).

Decentralized Clinical Trials: A Win For Patients, Sponsors, And Investigators

Decentralized trials are poised to play a major role in drug development post-pandemic. Learn the integral role Direct-to-Patient Services play in the execution of decentralized trials and how sponsors can maximize these benefits to improve drug development.

8 Criteria For A More Successful API Partnership

Save time and money by addressing these eight critical areas that are required for a fast, smooth API development process.

A Faster Path From Prefilled Syringe To Autoinjector

This webinar explores how to transition your product from prefilled syringe to autoinjector faster with a partner who can anticipate equipment and process needs.

029: The Effects Of Politics On Pharma

According to Outsourced Pharma chief editor, Louis Garguilo, “Politics has never played a bigger role in our (global) biopharma industry.” In this episode, we talk with Louis about three of his recent editorials that touch on this subject while also discussing the current IP debate in pharma and the origins of COVID-19.